美国2000-2015年有无不孕症治疗保险覆盖强制令各州卵胞浆内单精子注射的使用情况
该横断面分析利用美国国家辅助生殖技术监测系统,比较2000-2015年有IVF保险强制令的8个州与无强制令的43个州(含DC)居民的新鲜IVF周期中ICSI的使用情况。2000-2015年共1,356,377个新鲜IVF周期,其中25.8%(n=350,344)为强制令州居民。两州组ICSI使用均显著增加,但非男性因素周期中无强制令州增幅更大;2011-2015年强制令州ICSI使用率低于无强制令州。
要点
- 2000-2015年共1,356,377个新鲜IVF周期,25.8%(n=350,344)来自有保险强制令的州。
- 非男性因素周期ICSI占比:无强制令州由2000年34.6%升至2015年73.9%,强制令州由39.5%升至63.5%。
- 2011-2015年强制令州ICSI使用率低于无强制令州:有男性因素91.5% vs 94.5%,无男性因素60.3% vs 70.9%。
核心结论
- IVF保险覆盖强制令与无男性因素不孕周期中较低的ICSI使用相关。
研究设计与样本
- 横断面分析,数据来自美国国家辅助生殖技术监测系统,主要结局分析年份为2011-2015年,趋势分析年份为2000-2015年。
- 分析对象为美国生殖诊所进行的新鲜IVF周期。
- 按居住州分为有IVF保险强制令(n=8个州)与无强制令(n=43个州,包括DC)两组。
- 主要结局为按男性因素不孕诊断分层的ICSI使用情况。
主要发现
- 2000-2015年共1,356,377个新鲜IVF周期,其中25.8%(n=350,344)为有保险覆盖强制令州居民所行周期。
- 2000-2015年,有无强制令两州组ICSI使用均显著增加。
- 无男性因素不孕周期中,ICSI使用百分比增幅在无强制令州更大:由2000年34.6%升至2015年73.9%;强制令州由2000年39.5%升至2015年63.5%。
- 有男性因素不孕周期中,无论是否居住于有IVF保险强制令的州,ICSI使用百分比增幅约为7.3%。
- 2011-2015年,强制令州ICSI使用率低于无强制令州:有男性因素不孕周期为91.5% vs 94.5%,无男性因素不孕周期为60.3% vs 70.9%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare indications and trends in intracytoplasmic sperm injection (ICSI) use for in vitro fertilization (IVF) cycles among residents of states with and without insurance mandates for IVF coverage. DESIGN: Cross-sectional analysis of the National Assisted Reproductive Technology Surveillance System from 2011 to 2015 for the main outcome and from 2000 to 2015 for trends. SETTING: IVF cycles performed in U.S. fertility clinics. PATIENT(S): Fresh IVF cycles. INTERVENTION(S): Residency in a state with an insurance mandate for IVF (n = 8 states) versus no mandate (n = 43 states, including DC). MAIN OUTCOME MEASURE(S): ICSI use by insurance coverage mandate status stratified by male-factor infertility diagnosis. RESULT(S): During 2000-2015, there were 1,356,377 fresh IVF cycles, of which 25.8% (n = 350,344) were performed for residents of states with an insurance coverage mandate for IVF. ICSI use increased significantly during 2000-2015 in states both with and without a mandate; however, for non-male-factor infertility cycles, the percentage increase in ICSI use was greater among nonmandate states (34.6% in 2000 to 73.9% in 2015) versus mandate states (39.5% in 2000 to 63.5% in 2015). For male-factor infertility cycles, this percentage increase was ∼7.3% regardless of residency in a state with an insurance mandate for IVF. From 2011 to 2015, ICSI use was lower in mandate versus nonmandate states, both for cycles with (91.5% vs. 94.5%), and without (60.3% vs. 70.9%) male-factor infertility. CONCLUSION(S): Mandates for IVF coverage were associated with lower ICSI use for non-male-factor infertility cycles.
引用
- Dieke AC, Mehta A, Kissin DM, et al. Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015. Fertil Steril. 2018. PMID: 29580644. doi:10.1016/j.fertnstert.2017.12.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。